Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitorsJennifer Choi, Ronald Anderson, Ada Blidner, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2024
Patient-reported symptom monitoring: using (big) data to improve supportive care at the macro-, meso-, and micro-levelsYan Wang, Matthew J Allsop, Joel B Epstein, et al.Lung Cancer Management|August 11, 2020
Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancerBernardo L Rapoport, Annette J Theron, Daniel A Vorobiof, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
WBC Growth Factors: ASCO Guideline UpdateBishal Gyawali, Kari Bohlke, Jana K Dickter, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitorsMaria E Suarez-Almazor, Xerxes Pundole, Noha Abdel-Wahab, et al.Clinical Breast Cancer|August 24, 2017
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast CancerJosé Baselga, Claudio Zamagni, Patricia Gómez, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 11, 2010
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study groupMario E Lacouture, Michael L Maitland, Siegfried Segaert, et al.European Journal of Cancer (Oxford, England : 1990)|September 16, 2025
Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18Graham L Cohen, Corlia Coetzee, Cathryn A Walton, et al.NPJ Breast Cancer|December 2, 2021
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working GroupKhalid El Bairi, Harry R Haynes, Elizabeth Blackley, et al.Pageof 6